3, strong staining; and 4, maximal staining.
In each section, the number of positive cells per total number of tumor cells was counted at x 400 and a percentage of positivity was derived. This percentage was multiplied by the staining intensity of the cells to calculate an immunohistochemical reactivity score for each neoplasm (43).
Statistical Analysis.
Since the reactivity scores were cleanly not normally distributed, we used a non-parametric method to test for possible differences in reactivity scores between the four groups of melanocytic lesions. We first ranked all specimens in increasing order of their reactivity scores, assigning the value 1 to the lowest rank, 2 to the second lowest rank, and so on. Tied values were assigned the mean of the corresponding ranks. The one-way analysis ofvaniance test was performed on the ranks; a test for Iinear trend in group means was also carried out (44, 45) .
All values quoted
were two-sided.
The linear trend analysis was intended to test the hypothesis that neactivity with MAb 2-139-1 in these melanocytic neoplasms could be correlated with malignancy or their different potential for malignant transformation, from the low of the banal melanocytic nevus to the high of melanoma, which can metastasize and kill. Dysplastic melanocytic nevus was ranked immediately below melanoma because of its established role as an intermediate precursor in the evolution ofmalignant melanoma (46-49). Spitz's nevus was ranked below dysplastic nevus but above banal nevus because, despite its atypical histological features, it is a benign lesion, yet preliminary data suggest that it has some capacity for limited tumor progression but not for widespread metastasis and death (50) . To avoid the conflicting and confounding data on the potential for malignant transformation in congenital nevus (51, 52) , only very small (<1.0 cm in diameter) congenital nevi were studied. These very small lesions have no well-established increased risk ofmelanoma as compared with other types ofmelanocytic nevi (51,52), and were therefore included with the banal nevi.
Results

Immunostaining ofMal:gnant Melanoma
The cases of malignant melanoma consisted of 28 primary lesions and six metastatic tumors (Table  1) . Of the primary melanomas, 18 were common lesions involving the epidermis and dermis, three were melanoma in situ only, three were with a pre-existing nevus, two were spindle-cell melanomas, and two were undifferentiated neoplasms (5-100 positive). One of the primary lesions showed fo- 
Immunostaining ofMelanocytic Nevi
Most banal melanocytic nevi failed to show any reactivity with the antibody, and in those that did, the reactivity was very focal and in general of low intensity ( 
